TYME’s Novel Metabolic-Based Cancer Therapy, SM-88, Improves Survival in Phase II Study of Patients with Advanced Pancreatic Cancer
Tyme Technologies, Inc. (TYME)
Last tyme technologies, inc. earnings: 2/5 08:00 am
Check Earnings Report
US:NASDAQ Investor Relations:
tymeinc.com/investors
Company Research
Source: GlobeNewswire
68% of evaluable patients with actively progressing end-stage pancreatic cancer receiving monotherapy SM-88 remain alive with a median follow-up of 4.3 months (median 5.8 months from completing last therapy)Of 14 patients receiving SM-88 as third-line therapy, 79% remain alive after a median follow-up of 4.7 months; survival was more than double when compared to the median expected survival of third-line pancreatic patients based on historical trialsMedian reduction of 73% in circulating tumor cell burden was reported in evaluable patientsStudy supported SM-88’s existing favorable safety profile and was well tolerated as an oral monotherapy TYME plans to advance SM-88 third-line pancreatic cancer registrational regulatory strategy in 2019 based on study resultsSM-88 presentation scheduled for Friday, January 18th at American Society of Clinical Oncology’s (ASCO) 2019 Gastrointestinal Cancers Symposium NEW YORK, Jan. 18, 2019 (GLOBE NEWSWIRE) -- Tyme Technologies, Inc. (NASDAQ: TYME
Show less
Read more
Impact Snapshot
Event Time:
TYME
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
TYME alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
TYME alerts
High impacting Tyme Technologies, Inc. news events
Weekly update
A roundup of the hottest topics